USP22 and neoplasm: Mice that received injections of USP22‐deficient B16F10 cells exhibited a reduced metastatic burden, characterized by a lower number of lung micro‐metastases per lung section, as detected by hematoxylin–eosin (H&E) staining of tumor nodule specimens (Figure 2I).